Palexia Retard (Tapentadol)

Palexia is a brand of Tapentadol, a potent opioid analgesic used for managing severe chronic pain. It was originally developed and patented by the German pharmaceutical company Grünenthal. The manufacturing of these prolonged-release tablets typically occurs in Germany, specifically at the Grünenthal facilities in Aachen, though global distribution often involves local subsidiaries. Grünenthal remains the ultimate owner of the brand and is a family-owned research-driven pharmaceutical group headquartered in Germany, specializing in pain management and related therapies.